These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23424081)

  • 1. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
    Ronca R; Alessi P; Coltrini D; Di Salle E; Giacomini A; Leali D; Corsini M; Belleri M; Tobia C; Garlanda C; Bonomi E; Tardanico R; Vermi W; Presta M
    J Pathol; 2013 Jun; 230(2):228-38. PubMed ID: 23424081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.
    Giacomini A; Matarazzo S; Pagano K; Ragona L; Rezzola S; Corsini M; Di Salle E; Presta M; Ronca R
    Oncotarget; 2015 May; 6(15):13790-802. PubMed ID: 25912421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.
    Leali D; Alessi P; Coltrini D; Ronca R; Corsini M; Nardo G; Indraccolo S; Presta M
    Mol Cancer Ther; 2011 Sep; 10(9):1600-10. PubMed ID: 21764903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
    Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M
    Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo.
    Camozzi M; Zacchigna S; Rusnati M; Coltrini D; Ramirez-Correa G; Bottazzi B; Mantovani A; Giacca M; Presta M
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1837-42. PubMed ID: 16020751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
    Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M
    Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
    Ronca R; Di Salle E; Giacomini A; Leali D; Alessi P; Coltrini D; Ravelli C; Matarazzo S; Ribatti D; Vermi W; Presta M
    Mol Cancer Ther; 2013 Dec; 12(12):2760-71. PubMed ID: 24130051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide.
    Leali D; Bianchi R; Bugatti A; Nicoli S; Mitola S; Ragona L; Tomaselli S; Gallo G; Catello S; Rivieccio V; Zetta L; Presta M
    J Cell Mol Med; 2010 Aug; 14(8):2109-21. PubMed ID: 19627396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
    Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
    Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
    Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
    J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2.
    Presta M; Foglio E; Churruca Schuind A; Ronca R
    Front Immunol; 2018; 9():2327. PubMed ID: 30349543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.
    Leali D; Inforzato A; Ronca R; Bianchi R; Belleri M; Coltrini D; Di Salle E; Sironi M; Norata GD; Bottazzi B; Garlanda C; Day AJ; Presta M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):696-703. PubMed ID: 22267482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.
    Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M
    Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy.
    Ronca R; Giacomini A; Di Salle E; Coltrini D; Pagano K; Ragona L; Matarazzo S; Rezzola S; Maiolo D; Torrella R; Moroni E; Mazzieri R; Escobar G; Mor M; Colombo G; Presta M
    Cancer Cell; 2015 Aug; 28(2):225-39. PubMed ID: 26267536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.
    Maruyama-Takahashi K; Shimada N; Imada T; Maekawa-Tokuda Y; Ishii T; Ouchi J; Kusaka H; Miyaji H; Akinaga S; Tanaka A; Shitara K
    Prostate; 2008 May; 68(6):640-50. PubMed ID: 18213631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM
    Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.
    Ronca R; Tamma R; Coltrini D; Ruggieri S; Presta M; Ribatti D
    Oncotarget; 2017 Oct; 8(47):82583-82592. PubMed ID: 29137286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.
    Song Z; Powell WC; Kasahara N; van Bokhoven A; Miller GJ; Roy-Burman P
    Cancer Res; 2000 Dec; 60(23):6730-6. PubMed ID: 11118059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia.
    Song Z; Wu X; Powell WC; Cardiff RD; Cohen MB; Tin RT; Matusik RJ; Miller GJ; Roy-Burman P
    Cancer Res; 2002 Sep; 62(17):5096-105. PubMed ID: 12208767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.